Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery
Clinical trial NCT02540876 · COMPLETED
Trial details
- NCT number
- NCT02540876
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-08
- Primary completion
- 2019-02-08
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.